Results

Total Results: 199 records

Showing results for "end stage renal".

141. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
     March 01, 2012 - Based on this input, our overall assessment is that this intervention is in the lower end of the … glucose levels in urine were reported in some trials. 76 Additionally, long-term safety data on renal … Experts believe that the proposed mechanism of action of reducing blood glucose levels by preventing renal … Lilly and Amylin mutually agree to end diabetes alliance and transition exenatide responsibility to … Selected pharmaceuticals in late stage U.S. and E.U. development or registration.

142. Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
     February 01, 2012 - Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. … risk solid tumors Safety/Efficacy Study 12 4/1999- 9/2012 United States FU: Annually until end … Phase II treatment study 60 (ages 6 to 59 years) 9/1994 - End date not provided United States … weight) Systemic Lupus Erythematosus Disease Activity Index Lupus serology (ANA, dsDNA, C3, C4) Renal … Supportive care intervention 150 (75 per arm) 1/2004 – End date not reported United States

143. Meditation Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
     January 01, 2014 - • Was attrition <20% at the end of treatment? … One trial specified that the researchers looked for toxicities of meditation to hematologic, renal, … Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage … Change in women’s diet and body mass following intensive intervention for early-stage breast cancer … effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage

144. Disposition of Comments for Technical Brief 27 Patient Safety (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ambulatory-safety_disposition-comments.pdf
     October 19, 2016 - Thus my 1st several readings left me w/ a feeling that it seems to almost "end before it begins." … sentences, legible orders, medication list maintenance, some decision- support successes (allergies, renal … No response needed Peer Reviewer #5 Background I thought this set the stage nicely. … I assume that keeping them anonymous at this stage is standard practice, but it would help to have a … It is AHRQ practice to keep them anonymous at the draft stage.

145. Linking Dental Services to Treatment Outcomes for Diabetes: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
     November 01, 2024 - The program has begun to develop a range of rapid evidence products to assist end users in making specific … risk of all-cause mortality, highlighting the impact of oral health on cardiovascular, immune, and renal … Summarized are the details for each study regarding study location, funding source, DM stage, quality … , Outcomes Detail 13 Author, Year; Country; Funding Source; DM Stage; Quality Design; … Summarized are the details for each study regarding study location, funding source, DM stage, quality

146. Chronic-Urinary-Retention Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
     September 01, 2014 - the study questions, the EPC consulted a panel of Key Informants who represent subject experts and end-users … Therefore, in the end, study questions, design, methodological approaches, and/or conclusions do not … Because of their role as end-users, individuals with potential conflicts may be retained. … Open Label|Primary Purpose: Treatment NCT00878176 Sacral Neuromodulation Test With Bilateral First Stage … Patients with Non- obstructive Urinary Retention: A Pilot Study Urinary Retention Procedure: First stage

147. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
     January 01, 2012 - also increases the risk of several types of cancer including colorectal, endometrial, esophageal, renal … The phentermine plus topiramate combination is administered daily as an oral medication. 3 In late-stage … Based on this input, our overall assessment is that this intervention is in the higher end of the high-potential-impact … Based on this input, our overall assessment is that this intervention is in the lower end of the high

148. Hypertension-Pulmonary-Arterial Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
     April 01, 2013 - disease, thyroid disorders 5.4 Others: tumoral obstruction, fibrosing mediastinitis, chronic renal … Limited data suggest that epoprostenol and bosentan may provide a survival benefit; however, this end … At the full- text screening stage, two independent reviewers read each article to determine if it met … Of these, 1,127 were excluded at the full-text screening stage, leaving 197 articles (representing … – Consider studies of additional promising measures such as end diastolic pulmonary regurgitation

149. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - ITCA 650 pump system compared with twice-daily exenatide injections (Ex-BID) was evaluated in a two-stage … Stage II (n=131) re-randomly assigned patients to receive 20, 40, 60, or 80 mcg/day of ITCA 650 for … Stage I: mean change in HbA1c from a mean baseline of 7.9-8.0% was -0.98, -0.95, and -0.72% for the … Stage II: significant (P < 0.05) reductions in HbA1c (∼1.4% from baseline) were achieved with 60 and … This would require more patient followup to monitor renal function.

150. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
     January 01, 2016 - evaluated in a randomized phase II trial in patients with T2DM inadequately controlled with metformin.47 Stage … For Stage II, 131 subjects were re-randomly assigned to receive 20, 40, 60, or 80 mcg/day of ITCA 650 … Stage I: mean change in HbA1c from a mean baseline of 7.9-8.0% was -0.98, -0.95, and -0.72% for the … Stage II: significant 9 (P < 0.05) reductions in HbA1c (∼1.4% from baseline) were achieved with … This expert added that prescribing providers would need to be willing to monitor renal function in

151. Use of and access to health care by Medicare beneficiaries with diabetes: impact of diabetes type and insulin use, 2007-2011 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-medicare-use_research.pdf
     January 01, 2014 - Hispanic ethnicity.13,14 Age: The age categories were defined us- ing the age of the beneficiary at the end … *End stage renal disease (ESRD) is a subset of CKD. In 2011, 6.2% of CKD beneficiaries had ESRD.

152. Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
     January 15, 2015 - • Harms, risks and consequences of testing o Procedural harms, adverse events of testing (e.g., renal … Harms, risks and consequences of testing (both initial and subsequent testing) • Harms of testing (renal … Thus, to set the stage for the review’s Key Questions, which are focused on clinical decisionmaking … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

153. FRN 29: Future Research Needs on Procalcitonin-Guided Antibiotic Therapy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
     August 01, 2014 - Changes in outcomes from the beginning to the end of the study are compared across groups. … To that end, stratification may be needed to assess the contribution of procalcitonin in populations … Changes in outcomes from the beginning to the end of the study are compared across groups. … For patients with underlying stable chronic disease (e.g. diabetes, renal disease, but excluding immunocompromised … diabetes, renal disease, but excluding immunocompromised patients) and a high uncertainty of infection

154. Cad-Women-Diagnosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
     June 01, 2012 - contrast agent used during the procedure to visualize the coronary arteries may cause anaphylaxis, renal … During the topic refinement stage, we solicited input from Key Informants, representing clinicians ( … At the full-text screening stage, two independent reviewers read each article to determine if it met … At the full-text review stage, paired researchers independently reviewed the articles and indicated … Of these, 1,662 articles were excluded at the full-text screening stage.

155. Single-arm studies in comparative effectiveness reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
     January 01, 2013 - For example, in patients with end-stage liver disease, the natural history of disease is so well known … We excluded CERs at the draft stage at the time of the last search because draft reports have not been … As an example, the change in blood pressure is assessed in patients with renal artery stenosis before … For example, there may be variability in the stage of disease presentation of pathological features

156. Mass-Casualty-Events-Scarce-Resources Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mass-casualty-events-scarce-resources_executive.pdf
     June 01, 2012 - Each used a vastly different strategy and examined effectiveness using different end points. … rather than intervention studies, and only a few of these examined similar scenarios using similar end … available resources Medical interventions (2 studies) • Medical interventions for the prevention of acute renal … Time-based Triage) • Triage strategies (e.g., combining triage categories, adding categories, one- vs. two-stage

157. A Prospective Comparison of Evidence Synthesis Search Strategies Developed With and Without Text-Mining Tools (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-results-search-strategies-developed-with-without-text-mining-tools.pdf
     March 01, 2021 - Aromatherapy and Essential Oils: A Map of the Evidence25 Simple PubReminer, Yale MeSH Analyzer, Carrot2 End-stage … Renal Disease and Depression: A Systematic Review* Simple PubReminer, Carrot2, VOSviewer Gulf War … Tool | Web-Based Tool) MeSH on Demand is a National Library of Medicine (NLM) designed to analyze end-user … PubReMiner (Keyword/Phrase and Subject Term Tool | Web-Based Tool) PubReMiner analyzes end-user defined … I still find Carrot2 more useful for this stage as it clumps the references into topics, but I did

158. Heart-Failure-Transition-Care Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_executive.pdf
     May 01, 2014 - readmissions within 30 days were for HF; the remainder of readmissions were for diverse indications (e.g., renal … that 35 percent of 30-day readmissions are for HF; the remainder are for diverse indications (e.g., renal … Included trials commonly excluded patients who had end-stage renal disease or severe or unstable cardiovascular

159. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
     January 30, 2020 - transplantation : official publication of the European Dialysis and Transplant Association - European Renal … Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage … renal disease population unresponsive to primary vaccination series. … Renal failure. 2015;37(7):1080-8. 105. Zafack JG, De Serres G, Kiely M, et al. … Nervous system disorders • Pregnancy, puerperium and perinatal conditions • Psychiatric disorders • Renal

160. Defining an Optimal Format for Presenting Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
     January 01, 2019 - The interviewer identified themes after the end of each interview based on the discussions with the … rare harmful effects in randomized controlled trials 2006 JAMA 20197533 Higher vs lower positive end-expiratory … 17261117 Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage … renal disease: evidence for coverage decisions in Thailand 2007 Value Health 18263560 Identifying … groundwater remediation system 2008 Sci Total Environ 18697843 Determining optimal sample sizes for multi-stage